Abstract
Although scarce, available data suggest that the epidemiology of invasive aspergillosis (IA) in North Africa differs from northern countries, where more than 80 % is caused by Aspergillus fumigatus. This study aimed at describing the epidemiology of IA in the region of Sousse, Tunisia, and at assessing the usefulness of the available diagnostic tools. For 2 years, clinical and mycological data were prospectively collected from 175 neutropenia episodes of 91 patients hospitalised in the haematology department at the Farhat Hached hospital in Sousse (Tunisia). Screening for galactomannan antigen was positive in 40 % of neutropenia episodes; Aspergillus PCR was positive in 42 % of the tested sera. Nine patients were classified as probable and two as possible IA according to the EORTC/MSG criteria. Twelve patients who prematurely died, had no CT scan and could not be classified. Fifty-six Aspergillus spp. were isolated in 53 (6.5 %) sputa collected from 35 (20 %) patients. The following species were identified with MALDI-TOF mass spectrometry and DNA sequencing: A. niger, 35 %; A. flavus, 38 %; A. tubingensis, 19 %; A. fumigatus, 4 %; A. westerdijkiae, 2 % and A. ochraceus, 2 %. Our findings highlight the epidemiological features of IA in Tunisia, which is characterised by the predominance of Aspergillus spp. from sections Nigri and Flavi.
Similar content being viewed by others
References
Bergeron A, Porcher R, Menotti J, Poirot JL, Chagnon K, Vekhoff A, et al. Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients. J Clin Microbiol. 2012;50(3):823–30.
Chakrabarti A, Chatterjee SS, Das A, Shivaprakash MR. Invasive aspergillosis in developing countries. Med Mycol. 2011;49(Suppl 1):S35–47.
Chakrabarti A, Singh R. The emerging epidemiology of mould infections in developing countries. Curr Opin Infect Dis. 2011;24(6):521–6.
De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813–21.
Blot SI, Taccone FS, Van den Abeele A-M, Bulpa P, Meersseman W, Brusselaers N, et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2012;186(1):56–64.
De Hoog G, Guarro J, Gené J, Figueras M. Atlas of clinical Fungi. 2nd ed. Utrecht: Centraalbureau voor Schmmelcultures; 2000.
Cassagne C, Ranque S, Normand A-C, Fourquet P, Thiebault S, Planard C, et al. Mould routine identification in the clinical laboratory by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. PLoS ONE. 2011;6(12):e28425.
Ranque S, Normand A-C, Cassagne C, Murat J-B, Bourgeois N, Dalle F, et al. MALDI-TOF mass spectrometry identification of filamentous fungi in the clinical laboratory. Mycoses. 2014;57(3):135–40.
Hadrich I, Mary C, Makni F, Elloumi M, Dumon H, Ayadi A, et al. Comparison of PCR-ELISA and real-time PCR for invasive aspergillosis diagnosis in patients with hematological malignancies. Med Mycol. 2011;49(5):489–94.
Pagano L, Caira M, Candoni A, Offidani M, Martino B, Specchia G, et al. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study. Haematologica. 2010;95(4):644–50.
Denning DW. Invasive aspergillosis. Clin Infect Dis. 1998;26(4):781–803; quiz 804–5.
Hadrich I, Makni F, Sellami H, Cheikhrouhou F, Sellami A, Bouaziz H, et al. Invasive aspergillosis: epidemiology and environmental study in haematology patients (Sfax, Tunisia). Mycoses. 2010;53(5):443–7.
Greene R. The radiological spectrum of pulmonary aspergillosis. Med Mycol. 2005;43(Suppl 1):S147–54.
Godet C, Elsendoorn A, Roblot F. Benefit of CT scanning for assessing pulmonary disease in the immunodepressed patient. Diagn Interv Imaging. 2012;93(6):425–30.
Fontana C, Gaziano R, Favaro M, Casalinuovo I, Pistoia E, Di Francesco P. (1-3)-β-D-Glucan vs Galactomannan antigen in diagnosing invasive fungal infections (IFIs). Open Microbiol J. 2012;6:70–3.
Chai LYA, Kullberg B-J, Johnson EM, Teerenstra S, Khin LW, Vonk AG, et al. Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis. J Clin Microbiol. 2012;50(7):2330–6.
Aquino VR, Goldani LZ, Pasqualotto AC. Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis. Mycopathologia. 2007;163(4):191–202.
Mikulska M, Furfaro E, Del Bono V, Raiola AM, Ratto S, Bacigalupo A, et al. Piperacillin/tazobactam (Tazocin™) seems to be no longer responsible for false-positive results of the galactomannan assay. J Antimicrob Chemother. 2012;67(7):1746–8.
Johnson GL, Bibby DF, Wong S, Agrawal SG, Bustin SA. A MIQE-compliant real-time PCR assay for Aspergillus detection. PLoS ONE. 2012;7(7):e40022.
Bretagne S. Advances and prospects for molecular diagnostics of fungal infections. Curr Infect Dis Rep. 2010;12(6):430–6.
Ramos ER, Jiang Y, Hachem R, Kassis C, Kontoyiannis DP, Raad I. Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles. Oncologist. 2011;16(7):1049–60.
Hadrich I, Makni F, Neji S, Cheikhrouhou F, Bellaaj H, Elloumi M, et al. Amphotericin B in vitro resistance is associated with fatal Aspergillus flavus infection. Med Mycol. 2012;51:371–7.
Nivoix Y, Velten M, Letscher-Bru V, Moghaddam A, Natarajan-Amé S, Fohrer C, et al. Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis. 2008;47(9):1176–84.
Stevens DA, Kan VL, Judson MA, Morrison VA, Dummer S, Denning DW, et al. Practice guidelines for diseases caused by Aspergillus. Infectious diseases society of America. Clin Infect Dis. 2000;30(4):696–709.
Muñoz P, Alcalá L, Sánchez Conde M, Palomo J, Yáñez J, Pelaez T, et al. The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive of invasive aspergillosis. Transplantation. 2003;75(3):326–9.
Rüping MJGT, Gerlach S, Fischer G, Lass-Flörl C, Hellmich M, Vehreschild JJ, et al. Environmental and clinical epidemiology of Aspergillus terreus: data from a prospective surveillance study. J Hosp Infect. 2011;78(3):226–30.
Person AK, Chudgar SM, Norton BL, Tong BC, Stout JE. Aspergillus niger: an unusual cause of invasive pulmonary aspergillosis. J Med Microbiol. 2010;59(Pt 7):834–8.
Krishnan S, Manavathu EK, Chandrasekar PH. Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance. Mycoses. 2009;52(3):206–22.
Alanio A, Beretti J-L, Dauphin B, Mellado E, Quesne G, Lacroix C, et al. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for fast and accurate identification of clinically relevant Aspergillus species. Clin Microbiol Infect. 2011;17(5):750–5.
Morello LG, Sartori D, de Oliveira Martinez AL, Vieira MLC, Taniwaki MH, Fungaro MHP. Detection and quantification of Aspergillus westerdijkiae in coffee beans based on selective amplification of beta-tubulin gene by using real-time PCR. Int J Food Microbiol. 2007;119(3):270–6.
Hendrickx M, Beguin H, Detandt M. Genetic re-identification and antifungal susceptibility testing of Aspergillus section Nigri strains of the BCCM/IHEM collection. Mycoses. 2012;55(2):148–55.
Acknowledgments
This work was supported by the UR04SP24 Research Unit, from the Ministry of Health, Tunisia.
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gheith, S., Saghrouni, F., Bannour, W. et al. Characteristics of Invasive Aspergillosis in Neutropenic Haematology Patients (Sousse, Tunisia). Mycopathologia 177, 281–289 (2014). https://doi.org/10.1007/s11046-014-9742-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-014-9742-8